DiaSorin S.p.A. (OTCMKTS:DSRLF – Get Free Report) saw a large growth in short interest in February. As of February 28th, there was short interest totalling 218,900 shares, a growth of 58.9% from the February 13th total of 137,800 shares. Based on an average daily trading volume, of 100 shares, the short-interest ratio is presently 2,189.0 days. Currently, 0.4% of the company’s stock are sold short.
DiaSorin Stock Performance
DiaSorin stock remained flat at $109.60 during trading hours on Friday. The firm’s fifty day moving average price is $104.90 and its 200-day moving average price is $103.98. DiaSorin has a 1 year low of $100.26 and a 1 year high of $109.60.
Wall Street Analyst Weigh In
Separately, UBS Group lowered DiaSorin from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 26th.
About DiaSorin
DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.
Featured Stories
- Five stocks we like better than DiaSorin
- Insider Trading – What You Need to Know
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- 3 Monster Growth Stocks to Buy Now
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for DiaSorin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DiaSorin and related companies with MarketBeat.com's FREE daily email newsletter.
